Discontinuation rates of biologics in patients with rheumatoid arthritis: are TNF inhibitors different from non-TNF inhibitors?

OBJECTIVE: To compare discontinuation rates of first and second biologics in rheumatoid arthritis (RA) by tumour-necrosis factor inhibitor (TNFi) status and identify predictors and reasons for discontinuation. METHODS: From 1998 to 2011, self-reported medication use for RA was assessed every 6 month...

Descripción completa

Detalles Bibliográficos
Autores principales: Ramiro, Sofia, Landewé, Robert, van der Heijde, Désirée, Harrison, David, Collier, David, Michaud, Kaleb
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2015
Materias:
Rheumatoid Arthritis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4654098/
https://www.ncbi.nlm.nih.gov/pubmed/26629366
http://dx.doi.org/10.1136/rmdopen-2015-000155

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4654098/
https://www.ncbi.nlm.nih.gov/pubmed/26629366
http://dx.doi.org/10.1136/rmdopen-2015-000155

Ejemplares similares